Wellington Management Group LLP Trims Position in U.S. Physical Therapy, Inc. $USPH

Wellington Management Group LLP reduced its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 23.0% during the second quarter, Holdings Channel.com reports. The fund owned 88,496 shares of the company’s stock after selling 26,381 shares during the quarter. Wellington Management Group LLP’s holdings in U.S. Physical Therapy were worth $6,078,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of USPH. Hantz Financial Services Inc. raised its stake in shares of U.S. Physical Therapy by 56.4% during the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after acquiring an additional 132 shares in the last quarter. Huntington National Bank grew its stake in U.S. Physical Therapy by 15.4% in the fourth quarter. Huntington National Bank now owns 1,052 shares of the company’s stock worth $82,000 after purchasing an additional 140 shares in the last quarter. Osaic Holdings Inc. increased its holdings in U.S. Physical Therapy by 1.6% during the 2nd quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock worth $817,000 after purchasing an additional 166 shares during the period. Snowden Capital Advisors LLC increased its holdings in U.S. Physical Therapy by 3.6% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company’s stock worth $438,000 after purchasing an additional 195 shares during the period. Finally, Janney Montgomery Scott LLC raised its position in U.S. Physical Therapy by 6.7% during the 1st quarter. Janney Montgomery Scott LLC now owns 3,381 shares of the company’s stock valued at $253,000 after purchasing an additional 212 shares in the last quarter.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $77.83 on Thursday. The company has a market capitalization of $1.16 billion, a PE ratio of 457.88, a P/E/G ratio of 2.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.27 and a current ratio of 1.27. The company has a 50-day simple moving average of $76.82 and a two-hundred day simple moving average of $73.17. U.S. Physical Therapy, Inc. has a one year low of $58.19 and a one year high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm had revenue of $214.06 million for the quarter, compared to analysts’ expectations of $211.36 million. During the same period in the previous year, the company posted $0.81 earnings per share. The business’s quarterly revenue was up 8.5% compared to the same quarter last year. Research analysts expect that U.S. Physical Therapy, Inc. will post 2.95 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 21st will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $1.84 dividend on an annualized basis and a yield of 2.4%. U.S. Physical Therapy’s dividend payout ratio is presently 1,082.35%.

Analyst Ratings Changes

USPH has been the topic of a number of recent research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. Citizens Jmp restated a “market outperform” rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. Finally, Barrington Research upped their target price on U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $99.50.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.